SBFM Q1 2018 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$91,168

Gross Profit

-$9,651-10.6% margin

Operating Income

-$166,697-182.8% margin

Net Income

-$265,636-291.4% margin

EPS (Diluted)

$-5.64

QoQ Revenue Growth

+171.3%

Cash Flow

Operating Cash Flow

-$168,455

Free Cash Flow

-$173,238

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1M

Total Liabilities

$2M

Stockholders' Equity

-$500,685

Cash & Equivalents

$104,763

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$91,168	$0	—
Gross Profit	-$9,651	$0	—
Operating Income	-$166,697	-$108,990	-52.9%
Net Income	-$265,636	-$195,702	-35.7%